Company Analysis
Sign in

MaxCyte, Inc. (MXCT)

Nasdaq: MXCT · Services-Commercial Physical & Biological Research · Rockville, MD · filing with the SEC since 2004
Full chart Alerts Compare
Grade4.2
◀ Past 4.0● Present 4.7▶ Future 4.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

37 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to MaxCyte, Inc.’s names, not what it holds today.

Patents granted
37
21 design, 16 utility, 1976 to Dec 31, 2025
Granted in 2025
4
Against 3 in 2024 and 4 in 2023
Applications published
29
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
MAXCYTE, INC. its own name
US, as the owner printed on each patent
37 granted
18 published
MaxCyte, Inc. its own name
named as the applicant on its applications, in US
0 granted
11 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jul 29, 2025D1,086,051Electroporation gasketMAXCYTE, INC.
Apr 22, 2025D1,072,272Electroporation deviceMAXCYTE, INC.
Mar 11, 2025D1,066,728Bag used for sample or collectionMAXCYTE, INC.
Mar 11, 2025D1,066,718RackMAXCYTE, INC.
Dec 17, 2024D1,054,582Electroporation processing deviceMAXCYTE, INC.
Mar 12, 2024D1,017,609Docking stationMAXCYTE, INC.
Mar 5, 2024D1,016,816Docking stationMAXCYTE, INC.
Sep 12, 2023D998,821TrayMAXCYTE, INC.
Sep 5, 2023D998,173Electroporation gasketMAXCYTE, INC.
Mar 21, 202311,608,511Methods for modifying genomic DNABiotechnologyMAXCYTE, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jun 12, 20252025/0188494A METHOD OF CELL ELECTROPORATIONBiotechnologyMAXCYTE, INC.
Dec 5, 20242024/0401083A METHOD OF ENHANCED VIRAL TRANSDUCTION USING ELECTROPORATIONBiotechnologyMAXCYTE, INC.
Apr 6, 20232023/0103789SEQUENTIAL ELECTROPORATION METHODSBiotechnologyMAXCYTE, INC.
Aug 25, 20222022/0265722ENGINEERING AND DELIVERY OF THERAPEUTIC COMPOSITIONS OF FRESHLEY ISOLATED CELLSBiotechnologyMaxCyte, Inc.
Dec 23, 20212021/0395721METHODS TO IMPROVE POTENCY OF ELECTROPORATIONBiotechnologyMAXCYTE, INC.
Nov 11, 20212021/0348109SYSTEMS AND METHODS FOR ELECTROPORATIONBiotechnologyMAXCYTE, INC.
Oct 22, 20202020/0330519ENGINEERING AND DELIVERY OF THERAPEUTIC COMPOSITIONS OF FRESHLEY ISOLATED CELLSBiotechnologyMaxCyte, Inc.
Oct 8, 20202020/0318140METHODS AND COMPOSITIONS FOR INCREASING RNA ACTIVITY IN A CELLBiotechnologyMaxCyte, Inc.
Jul 30, 20202020/0237825ENGINEERING AND DELIVERY OF THERAPEUTIC COMPOSITIONS OF FRESHLY ISOLATED CELLSBiotechnologyMAXCYTE, INC.
Aug 15, 20192019/0247436METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNAPharmaceuticalsMaxCyte, Inc.
What it applied for, 2024 to 2025: Biotechnology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton MXCT · research, not advice